Please use this identifier to cite or link to this item: https://doi.org/10.21256/zhaw-3822
Full metadata record
DC FieldValueLanguage
dc.contributor.authorLaternser, Sandra-
dc.contributor.authorKeller, Hansjoerg-
dc.contributor.authorLeupin, Olivier-
dc.contributor.authorRausch, Martin-
dc.contributor.authorGraf-Hausner, Ursula-
dc.contributor.authorRimann, Markus-
dc.date.accessioned2018-07-03T14:18:29Z-
dc.date.available2018-07-03T14:18:29Z-
dc.date.issued2018-06-12-
dc.identifier.issn2472-6303de_CH
dc.identifier.issn2472-6311de_CH
dc.identifier.urihttps://digitalcollection.zhaw.ch/handle/11475/7548-
dc.description.abstractTwo-dimensional (2D) cell cultures do not reflect the in vivo situation, and thus it is important to develop predictive three-dimensional (3D) in vitro models with enhanced reliability and robustness for drug screening applications. Treatments against muscle-related diseases are becoming more prominent due to the growth of the aging population worldwide. In this study, we describe a novel drug screening platform with automated production of 3D musculoskeletal-tendon-like tissues. With 3D bioprinting, alternating layers of photo-polymerized gelatin-methacryloyl-based bioink and cell suspension tissue models were produced in a dumbbell shape onto novel postholder cell culture inserts in 24-well plates. Monocultures of human primary skeletal muscle cells and rat tenocytes were printed around and between the posts. The cells showed high viability in culture and good tissue differentiation, based on marker gene and protein expressions. Different printing patterns of bioink and cells were explored and calcium signaling with Fluo4-loaded cells while electrically stimulated was shown. Finally, controlled co-printing of tenocytes and myoblasts around and between the posts, respectively, was demonstrated followed by co-culture and co-differentiation. This screening platform combining 3D bioprinting with a novel microplate represents a promising tool to address musculoskeletal diseases.de_CH
dc.language.isoende_CH
dc.publisherSagede_CH
dc.relation.ispartofSLAS Technology: Translating Life Sciences Innovationde_CH
dc.rightshttp://creativecommons.org/licenses/by-nc/4.0/de_CH
dc.subject3D bioprintingde_CH
dc.subject3D cell culturede_CH
dc.subjectBioinkde_CH
dc.subjectDrug developmentde_CH
dc.subjectMuscle tissue engineeringde_CH
dc.subject.ddc610: Medizin und Gesundheitde_CH
dc.titleA novel microplate 3D bioprinting platform for the engineering of muscle and tendon tissuesde_CH
dc.typeBeitrag in wissenschaftlicher Zeitschriftde_CH
dcterms.typeTextde_CH
zhaw.departementLife Sciences und Facility Managementde_CH
zhaw.organisationalunitInstitut für Chemie und Biotechnologie (ICBT)de_CH
dc.identifier.doi10.21256/zhaw-3822-
dc.identifier.doi10.1177/2472630318776594de_CH
dc.identifier.pmid29895208de_CH
zhaw.funding.euNode_CH
zhaw.issue6de_CH
zhaw.originated.zhawYesde_CH
zhaw.pages.end613de_CH
zhaw.pages.start599de_CH
zhaw.publication.statuspublishedVersionde_CH
zhaw.volume23de_CH
zhaw.publication.reviewPeer review (Publikation)de_CH
zhaw.webfeed3D Gewebe und Biofabrikationde_CH
Appears in collections:Publikationen Life Sciences und Facility Management

Files in This Item:
File Description SizeFormat 
Laternser2018 muscle bioprinting.pdf974.23 kBAdobe PDFThumbnail
View/Open
Show simple item record
Laternser, S., Keller, H., Leupin, O., Rausch, M., Graf-Hausner, U., & Rimann, M. (2018). A novel microplate 3D bioprinting platform for the engineering of muscle and tendon tissues. SLAS Technology: Translating Life Sciences Innovation, 23(6), 599–613. https://doi.org/10.21256/zhaw-3822
Laternser, S. et al. (2018) ‘A novel microplate 3D bioprinting platform for the engineering of muscle and tendon tissues’, SLAS Technology: Translating Life Sciences Innovation, 23(6), pp. 599–613. Available at: https://doi.org/10.21256/zhaw-3822.
S. Laternser, H. Keller, O. Leupin, M. Rausch, U. Graf-Hausner, and M. Rimann, “A novel microplate 3D bioprinting platform for the engineering of muscle and tendon tissues,” SLAS Technology: Translating Life Sciences Innovation, vol. 23, no. 6, pp. 599–613, Jun. 2018, doi: 10.21256/zhaw-3822.
LATERNSER, Sandra, Hansjoerg KELLER, Olivier LEUPIN, Martin RAUSCH, Ursula GRAF-HAUSNER und Markus RIMANN, 2018. A novel microplate 3D bioprinting platform for the engineering of muscle and tendon tissues. SLAS Technology: Translating Life Sciences Innovation. 12 Juni 2018. Bd. 23, Nr. 6, S. 599–613. DOI 10.21256/zhaw-3822
Laternser, Sandra, Hansjoerg Keller, Olivier Leupin, Martin Rausch, Ursula Graf-Hausner, and Markus Rimann. 2018. “A Novel Microplate 3D Bioprinting Platform for the Engineering of Muscle and Tendon Tissues.” SLAS Technology: Translating Life Sciences Innovation 23 (6): 599–613. https://doi.org/10.21256/zhaw-3822.
Laternser, Sandra, et al. “A Novel Microplate 3D Bioprinting Platform for the Engineering of Muscle and Tendon Tissues.” SLAS Technology: Translating Life Sciences Innovation, vol. 23, no. 6, June 2018, pp. 599–613, https://doi.org/10.21256/zhaw-3822.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.